文献速递重症综合管理与镇静镇痛

基于观察与预测ICU死亡率评估远程ICU实施效果:系统评价与Meta分析

Evaluating Tele-ICU Implementation Based on Observed and Predicted ICU Mortality: A Systematic Review and Meta-Analysis.
PubMed 文献 · Crit Care Med · 2019-01-01
一句话结论远程ICU实施与ICU总体死亡率降低相关(OR 0.75),但获益仅见于实施前观察与预测死亡率比值大于1的亚组。

该系统评价与Meta分析检索PubMed、Cochrane Library、Embase和欧洲重症医学会数据库至2018年9月18日,纳入13项研究,评估远程ICU实施对ICU死亡率的影响。实施前后远程ICU的ICU总体死亡率汇总OR为0.75(95%CI 0.65-0.88;P<0.001)。亚组分析显示,实施前观察与预测死亡率比值大于1的亚组汇总OR为0.64(95%CI 0.52-0.77;P<0.001),比值小于1的亚组汇总OR为0.98(95%CI 0.81-1.18;P=0.81),交互作用检验P=0.002。作者认为远程ICU实施与ICU死亡率总体降低相关,但获益集中于实施前观察与预测死亡率比值大于1的机构,未来需用患者层面数据确认。

要点

  • 远程ICU实施前后ICU总体死亡率汇总OR为0.75(95%CI 0.65-0.88;P<0.001),提示实施与死亡率降低相关。
  • 实施前观察与预测ICU死亡率比值大于1的亚组,实施后死亡率汇总OR为0.64(95%CI 0.52-0.77;P<0.001)。
  • 实施前观察与预测ICU死亡率比值小于1的亚组,实施后死亡率汇总OR为0.98(95%CI 0.81-1.18;P=0.81),未达统计学显著。
  • 两亚组交互作用检验P=0.002,提示实施前观察与预测死亡率比值可能修饰远程ICU的死亡率效应。
  • 作者认为未来研究应使用患者层面数据确认该发现。

适用人群与场景

  • 纳入符合入选标准、评估远程ICU实施对ICU死亡率影响的所有试验中所包含的ICU患者。

诊断标准与关键阈值

  • 以实施前观察与预测ICU死亡率比值大于1或小于1进行亚组划分。

研究设计与关键结果

  • 研究类型为系统评价与Meta分析,纳入13项研究,检索PubMed、Cochrane Library、Embase和欧洲重症医学会数据库至2018年9月18日。
  • 远程ICU实施前后ICU总体死亡率汇总OR为0.75(95%CI 0.65-0.88;P<0.001)。
  • 实施前观察与预测死亡率比值大于1亚组的ICU死亡率汇总OR为0.64(95%CI 0.52-0.77;P<0.001)。
  • 实施前观察与预测死亡率比值小于1亚组的ICU死亡率汇总OR为0.98(95%CI 0.81-1.18;P=0.81)。
  • 两亚组交互作用检验P=0.002。

证据类型、等级与局限

  • 证据类型为系统评价与Meta分析。
  • 作者结论:远程ICU实施与ICU总体死亡率降低相关;亚组分析提示实施前观察与预测ICU死亡率比值大于1的发表文献与实施后ICU死亡率降低相关,比值小于1的亚组未见显著死亡率降低。
  • 局限:作者指出未来研究应使用患者层面数据确认该发现。

对床旁实践的改变

  • 作者认为,远程ICU实施与ICU总体死亡率降低相关,但该获益似乎集中于实施前观察与预测ICU死亡率比值大于1的机构;作者建议未来研究使用患者层面数据确认该发现。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Past studies have examined numerous components of tele-ICU care to decipher which elements increase patient and institutional benefit. These factors include review of the patient chart within 1 hour, frequent collaborative data reviews, mechanisms for rapid laboratory/alert review, and interdisciplinary rounds. Previous meta-analyses have found an overall ICU mortality benefit implementing tele-ICU, however, subgroup analyses found few differences. The purpose of this systematic review and meta-analysis was to explore the effect of tele-ICU implementation with regard to ICU mortality and explore subgroup differences via observed and predicted mortality.

DATA SOURCES: We searched PubMed, Cochrane Library, Embase, and European Society of Intensive Care Medicine for articles related to tele-ICU from inception to September 18, 2018.

STUDY SELECTION: We included all trials meeting inclusion criteria which looked at the effect of tele-ICU implementation on ICU mortality.

DATA EXTRACTION: We abstracted study characteristics, patient characteristics, severity of illness scores, and ICU mortality rates.

DATA SYNTHESIS: We included 13 studies from 2,766 abstracts identified from our search strategy. The before-after tele-ICU implementation pooled odds ratio for overall ICU mortality was 0.75 (95% CI, 0.65-0.88; p < 0.001). In subgroup analysis, the pooled odds ratio for ICU mortality between the greater than 1 versus less than 1 observed to predicted mortality ratios was 0.64 (95% CI, 0.52-0.77; p < 0.001) and 0.98 (95% CI, 0.81-1.18; p = 0.81), respectively. Test for interaction was significant (p = 0.002).

CONCLUSIONS: After evaluating all included studies, tele-ICU implementation was associated with an overall reduction in ICU mortality. Subgroup analysis suggests that publications exhibiting observed to predicted ICU mortality ratios of greater than 1 before tele-ICU implementation was associated with a reduction in ICU mortality after tele-ICU implementation. No significant ICU mortality reduction was noted in the subgroup of observed to predicted ICU mortality ratio less than 1 before tele-ICU implementation. Future studies should confirm this finding using patient-level data.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Fusaro MV, Becker C, Scurlock C, et al. Evaluating Tele-ICU Implementation Based on Observed and Predicted ICU Mortality: A Systematic Review and Meta-Analysis. Crit Care Med. 2019. PMID: 30688718. doi:10.1097/CCM.0000000000003627

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。